Nanotechnology Now - Press Release: Sanjay Gupta, Abraxis Senior Vice President and Advisor to the Executive Chairman, Named Young Global Leader by the World Economic Forum

Home > Press > Sanjay Gupta, Abraxis Senior Vice President and Advisor to the Executive Chairman, Named Young Global Leader by the World Economic Forum

Abstract:
Abraxis BioScience, Inc. (NASDAQ: ABII), a fully integrated biotechnology company, today announced Sanjay Gupta has been chosen by the World Economic Forum for its 2010 class of Young Global Leaders.

Sanjay Gupta, Abraxis Senior Vice President and Advisor to the Executive Chairman, Named Young Global Leader by the World Economic Forum

Los Angeles, CA | Posted on March 3rd, 2010

The honor, bestowed each year by the Forum, recognizes and acknowledges between 100 and 200 outstanding young leaders from around the world for their professional accomplishments, commitment to society and potential to contribute to shaping the future of the world.

The Forum has nominated Young Global Leaders from 72 countries, including business leaders, as well as leaders from government, academia, non-profit organizations, media and society. The new class represents all regions: East Asia (43), Europe (46), the Middle East and North Africa (14), North America (38), South Asia (21), sub-Saharan Africa (17) and Latin America (18).

Drawn from a pool of thousands of candidates, the Young Global Leaders 2010 were chosen by a selection committee, chaired by H.M. Queen Rania Al Abdullah of the Hashemite Kingdom of Jordan, comprising 31 eminent international media leaders.

Rachel Maddow of MSNBC, the tennis player Roger Federer, and the co-founder of Twitter, Evan Williams, are among those selected this year. Recipients in prior years include the co-founders of Google, Larry Page and Sergey Brin, the founder and CEO of Facebook, Mark Zuckerberg, and the television journalist Anderson Cooper.

Gupta, a second-generation Indian-American, is the Senior Vice President and Advisor to the Executive Chairman of Abraxis BioScience (NASDAQ: ABII), a leading pharmaceutical and health-care innovator based in the United States with offices throughout the world.

"We are delighted that Sanjay has been recognized for his past and ongoing contributions to social progress through his innovative thinking, vision, and leadership," said Patrick Soon-Shiong, M.D., Executive Chairman of Abraxis BioScience, in commenting on Gupta's selection for the 2010 YGL Class. "We look forward to supporting his commitment to improving society and the ideals of the Young Global Leaders at the World Economic Forum."

Prior to joining Abraxis, Gupta was recruited to serve as the Director of Social Enterprise at Intel Corporation by then General Counsel, Bruce Sewell, now General Counsel of Apple Computer. Earlier, Gupta served as the Chief Financial Officer and Director of Strategy for Dossia, a social-enterprise sponsored by Intel, Wal-Mart, Pitney-Bowes, AT&T, sanofi-aventis, Cardinal Health, Vanguard Health, Abraxis BioScience, Applied Materials, and BP America. At Dossia, Gupta served the Executive Committee, led by Dr. Craig Barrett, the retired Chairman and CEO of Intel, Michael J. Critelli, the retired Chairman and CEO of Pitney-Bowes, Inc., Jean-Paul Gagnon, the Chairman of the Dossia Consortium and Director at sanofi-aventis, and Dr. Patrick Soon-Shiong.

Commenting on the announcement, Gupta stated, "I am deeply honored to be a member of the 2010 Class of Young Global Leaders and I look forward to working with the YGL community around the world to advance a host of innovative and socially-beneficial initiatives. I'd like to thank Dr. Barrett, Mr. Critelli, and Dr. Soon-Shiong for their support and mentorship."

Gupta was previously Managing Director and Founder of REALSTRATEGY, a boutique strategy consulting firm based in the United States, and was also a Partner at Geo Health Partners, an investment partnership which focused on health care investments domestically and internationally. In his role as Director of Social Enterprise for Intel, Gupta researched and promoted models for investment in social enterprise and their potential for stimulating disruptive innovation in developing economies.

Gupta was educated at the University of Oxford, where he earned his MBA and was a member of Merton College. He earned his AB in Philosophy at Georgetown University and also studied Bioethics at the Kennedy Institute of Ethics. He has served as a Board member and advisor to numerous start-ups with a particular interest in sustainable social enterprise.

Established in 2004 by Professor Klaus Schwab, The Forum of Young Global Leaders is a multistakeholder community of the world's most extraordinary young leaders who dedicate a part of their time to jointly address global challenges and who are committed to devote part of their knowledge and energy to collectively work towards a better future. Together the Young Global Leaders work to discover innovative solutions to today's most pressing problems through various initiatives and workstreams as well as catalyzing the next generation of leaders.

####

About Abraxis BioScience
Abraxis BioScience is a fully integrated global biotechnology company dedicated to the discovery, development and delivery of next-generation therapeutics and core technologies that offer patients safer and more effective treatments for cancer and other critical illnesses. The company's portfolio includes the world's first and only protein-bound nanoparticle chemotherapeutic compound (ABRAXANE®), which is based on the company's proprietary tumor targeting technology known as the nab® platform. The first FDA approved product to use this nab platform, ABRAXANE, was launched in 2005 for the treatment of metastatic breast cancer and is now approved in 39 countries. The company continues to expand the nab platform through a robust clinical program and deep product pipeline. Abraxis trades on the NASDAQ Global Market under the symbol ABII. For more information about the company and its products, please visit www.abraxisbio.com.

For more information, please click here

Contacts:
Investors and Media Inquiries:
Abraxis BioScience, Inc.
Maili Bergman
Director Investor Relations & Corporate Communications
310-883-1300

or
PondelWilkinson Inc.
Rob Whetstone
310-279-5963

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark: